Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00741208 · ClinicalTrials.gov registry record · NA
Modification of Asthma With Soy Isoflavone
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00741208: Completed NA study, sponsored by Northwestern University.
NCT00741208 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00741208, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if dietary supplementation with soy isoflavones in persistent asthma improves airway reactivity as determined by PC20 to methacholine.
Interventions
- DIETARY_SUPPLEMENT Soy Isoflavone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-11 |
| Phase | NA |
What the finished NCT00741208 record still lists
NCT00741208 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Soy Isoflavone is the first listed.
NCT00741208 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00741208 about?
NCT00741208 is a clinical study titled "Modification of Asthma With Soy Isoflavone". The purpose of this study is to determine if dietary supplementation with soy isoflavones in persistent asthma improves airway reactivity as determined by PC20 to methacholine.
What is the current status of trial NCT00741208?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2008-08. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00741208?
The interventions under investigation include: Soy Isoflavone (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00741208?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00741208's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia